Market News
Global Artificial Intelligence (AI) in Genomics Market: Key Developments
- On February 16 2023, Accenture, has made a strategic investment, through Accenture Ventures, in Ocean Genomics, a technology and AI company that has developed advanced computational platforms to assist biopharma companies to discover and develop more effective diagnostics and therapeutics.
- In October 2020, NVIDIA announced a partnership with global healthcare company GSK and its AI group, which is applying computation to the drug and vaccine discovery process. GSK has recently established a new London-based AI hub, one of the first of its kind, which will leverage GSK’s significant genetic and genomic data to improve the process of designing and developing transformational medicines and vaccines.